Howard University Center for Sickle Cell disease

Washington D.C., District of Columbia 20060

0 studies enrolling now · 4 studies all time

What they study most

Anemia, Sickle Cell, Pain Crisis, Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders, Vaso-occlusive Crisis

Studies at this site

• Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) — Running, not enrolling
• Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
• A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) — Completed
• Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease — Stopped early